Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52,667 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The features of male breast cancer in China: A real-world study.
Gao Y, Zhang M, Sun G, Ma L, Nie J, Yuan Z, Liu Z, Cao Y, Li J, Liu Q, Ye S, Chen B, Song Y, Wang K, Ren Y, Ye G, Xu L, Liu S, Chen Q, Li W, Chen X, Fu P, Wei W, Guo B, Wang H, Cai Z, Du C, Wu Z, Zha X, Huang H, Xu J, Zhang C, Shi Y, Liu T, Liu S, Jiang Z, Lin Y. Gao Y, et al. Among authors: lin y. Breast. 2024 Aug;76:103762. doi: 10.1016/j.breast.2024.103762. Epub 2024 Jun 22. Breast. 2024. PMID: 38924994 Free PMC article.
Inflammatory pseudotumor of the liver.
Li GH, Li JQ, Lin YZ. Li GH, et al. Among authors: lin yz. J Surg Oncol. 1989 Dec;42(4):244-8. doi: 10.1002/jso.2930420409. J Surg Oncol. 1989. PMID: 2687584 Review.
Impact of Homologous Recombination Deficiency on Outcomes in Patients With Triple-Negative Breast Cancer Treated With Carboplatin-Based Neoadjuvant Chemotherapy: Secondary Analysis of the NeoCART Randomized Clinical Trial.
Zhang L, Wu Z, Li J, Zhu D, Yang L, Shao Y, Lin Y, Liu Z, Cao Y, Zhang G, Shang S, Zhang Y, Wang K. Zhang L, et al. Among authors: lin y. JCO Precis Oncol. 2023 Jan;7:e2200337. doi: 10.1200/PO.22.00337. JCO Precis Oncol. 2023. PMID: 36652665 Clinical Trial.
Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study.
Huang Y, Zhu T, Zhang X, Li W, Zheng X, Cheng M, Ji F, Zhang L, Yang C, Wu Z, Ye G, Lin Y, Wang K. Huang Y, et al. Among authors: lin y. EClinicalMedicine. 2023 Mar 24;58:101899. doi: 10.1016/j.eclinm.2023.101899. eCollection 2023 Apr. EClinicalMedicine. 2023. PMID: 37007742 Free PMC article.
Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial.
Xu B, Zhang Q, Hu X, Li Q, Sun T, Li W, Ouyang Q, Wang J, Tong Z, Yan M, Li H, Zeng X, Shan C, Wang X, Yan X, Zhang J, Zhang Y, Wang J, Zhang L, Lin Y, Feng J, Chen Q, Huang J, Zhang L, Yang L, Tian Y, Shang H. Xu B, et al. Among authors: lin y. Acta Pharm Sin B. 2023 May;13(5):2250-2258. doi: 10.1016/j.apsb.2023.02.001. Epub 2023 Feb 9. Acta Pharm Sin B. 2023. PMID: 37250148 Free PMC article. Clinical Trial.
52,667 results
You have reached the last available page of results. Please see the User Guide for more information.